MIYA-BM

· Osel, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MIYA-BM, covering 2013-11-11 to 2013-11-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections [Phase 2]

See pricing